Session » Muscle Biology, Myositis and Myopathies Poster
-
Abstract Number: 280
The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases
-
Abstract Number: 281
Health Related Quality of Life Is Reduced in Adult Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 282
Angiogenesis in Fasciitis Associated with Dermatomyositis
-
Abstract Number: 283
Altered Serum Fatty Acid Profiles in Patients with Polymyositis or Dermatomyositis Compared to Healthy Individuals and in Relation to Immunosuppressive Treatment
-
Abstract Number: 284
Validation of the Sporadic Inclusion Body Myositis Physical Functioning Assessment
-
Abstract Number: 287
Interleukin-35 in Idiopathic Inflammatory Myopathies
-
Abstract Number: 288
Myositis Associated Interstitial Lung Disease: Clinical Predictors of Failure to Conventional Treatment and Their Response to Tacrolimus
-
Abstract Number: 289
Evaluation of Usefulness of Krebs Von Den Lungen-6 As a Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including in the Short Time Course after Treatment
-
Abstract Number: 291
Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study
-
Abstract Number: 292
Neoepitope Biomarkers As Biomarkers of Polymyositis and Dermatomyositis and Functional Status
-
Abstract Number: 293
Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 294
A Decline in Pulmonary Function over One Year Predicts Outcome in Myositis-Associated Interstitial Lung Disease
-
Abstract Number: 295
Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index Among Dermatologists, Rheumatologists, and Neurologists
-
Abstract Number: 296
Different Patterns of Involvement of Thigh Muscles in Dermatomyositis and Polymyositis Using Fat-Suppressed Magnetic Resonance Sequences
-
Abstract Number: 297
How Useful Is Magnetic Resonance Imaging (MRI) in Monitoring Patients with Myositis?
-
Abstract Number: 298
Investigating the Pathogenic Role of ER Stress Pathway Activation in the Idiopathic Inflammatory Myopathies (IIM): Skeletal Muscle Cells As a Source of Cytokines (Myokines)
-
Abstract Number: 299
Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody
-
Abstract Number: 300
Causes of Creatine Kinase Levels Greater Than 1,000 IU/L in Patients Referred to Rheumatology
-
Abstract Number: 301
Economic Burden of Sporadic Inclusion Body Myositis in the United States of America: A Retrospective Cohort Study
-
Abstract Number: 302
Resource Utilization in a US Sample of Patients with Sporadic Inclusion Body Myositis
-
Abstract Number: 303
Mining RNA-Seq of Peripheral Blood Mononuclear Cells from JDM Alone Compared with JDM Plus Psoriasis for Biomarkers of Disease Activity
-
Abstract Number: 304
Abnormal Pulmonary Function Tests, Interstitial Lung Disease, and Lung Function Decline in Patients with Classic and Clinically Amyopathic Dermatomyositis
-
Abstract Number: 305
The “Sleeve Sign”� in Dermatomyositis
-
Abstract Number: 307
Screening for Pulmonary Hypertension in the Anti-Synthetase Syndrome; Utility of Four Different Screening Approaches
-
Abstract Number: 308
Nailfold Capillaroscopy in Patients with Early Onset-Dermatomyositis